Indo US Bio-Tech Ltd
09 Aug 2024 12:00 AM
Indo US Bio-Tech standalone net profit rises 33.76% in the June 2024 quarter,
Net profit of Indo US Bio-Tech rose 33.76% to Rs 3.17 crore in the quarter ended June 2024 as against Rs 2.37 crore during the previous quarter ended June 2023. Sales rose 29.15% to Rs 24.72 crore in the quarter ended June 2024 as against Rs 19.14 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales24.7219.14 29 OPM %14.9315.62 - PBDT3.392.65 28 PBT3.192.45 30 NP3.172.37 34 Powered by Capital Market - Live News
Indo US Bio-Tech Ltd
02 Aug 2024 12:00 AM
Indo US Bio-Tech to announce Quarterly Result,
Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 8 August 2024.Powered by Capital Market - Live News
Indo US Bio-Tech Ltd
03 May 2024 12:00 AM
Indo US Bio-Tech standalone net profit declines 81.23% in the March 2024 quarter,
Net profit of Indo US Bio-Tech declined 81.23% to Rs 0.52 crore in the quarter ended March 2024 as against Rs 2.77 crore during the previous quarter ended March 2023. Sales declined 12.92% to Rs 15.77 crore in the quarter ended March 2024 as against Rs 18.11 crore during the previous quarter ended March 2023.For the full year,net profit rose 13.95% to Rs 8.25 crore in the year ended March 2024 as against Rs 7.24 crore during the previous year ended March 2023. Sales rose 17.98% to Rs 72.84 crore in the year ended March 2024 as against Rs 61.74 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales15.7718.11 -13 72.8461.74 18 OPM %6.2117.06 -14.8315.19 - PBDT0.832.84 -71 9.618.22 17 PBT0.632.63 -76 8.817.39 19 NP0.522.77 -81 8.257.24 14 Powered by Capital Market - Live News
Indo US Bio-Tech Ltd
26 Apr 2024 12:00 AM
Indo US Bio-Tech schedules board meeting,
Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 2 May 2024.Powered by Capital Market - Live News
Indo US Bio-Tech Ltd
15 Feb 2024 12:00 AM
Indo US Bio-Tech standalone net profit rises 168.61% in the December 2023 quarter,
Net profit of Indo US Bio-Tech rose 168.61% to Rs 3.68 crore in the quarter ended December 2023 as against Rs 1.37 crore during the previous quarter ended December 2022. Sales rose 42.65% to Rs 22.11 crore in the quarter ended December 2023 as against Rs 15.50 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales22.1115.50 43 OPM %19.1313.23 - PBDT3.941.64 140 PBT3.751.35 178 NP3.681.37 169 Powered by Capital Market - Live News
Subscribe for our
newsletter
newsletter